Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs - Wikidata - awgldk - TriplyDB

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

http://www.wikidata.org/entity/Q24678651

about

Management of Multiple Sclerosis in the Breastfeeding Mother Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective Treatment of pregnant women with a diagnosis of inflammatory bowel disease Managing inflammatory bowel disease in pregnancy: current perspectives How I treat my inflammatory bowel disease-patients with thiopurines?Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.Utility of maternal 6-thioguanine nucleotide levels in predicting neonatal pancytopenia.Pregnancy and breastfeeding in patients with Crohn's disease.Management of distal ulcerative colitis: frequently asked questions analysis.Is breastfeeding safe with azathioprine?Management of the pregnant IBD patient.Management of early aggressive rheumatoid arthritis during pregnancy and lactation.From conception to delivery: managing the pregnant inflammatory bowel disease patient.The Asia-Pacific consensus on ulcerative colitis.Inflammatory bowel disease and pregnancy: an update.Thiopurine therapy in inflammatory bowel disease.European evidenced-based consensus on reproduction in inflammatory bowel disease.Safety considerations: breastfeeding after transplant.IBD medications during pregnancy and lactation.Vaccinating the inflammatory bowel disease patient.Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation.A practical guide to the use of thiopurines in oral medicine.Management of Eosinophilic Esophagitis During Pregnancy.Managing IBD Therapies in Pregnancy.Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy.Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease.

P2860

Q26766337-6D85CC33-5C76-4EF0-AD94-9808985598D5 Q26996946-B15344ED-BCF9-4D6C-9A62-09D0ED96809B Q27004038-EB30F5CF-E460-4869-953E-1BE0779AF2A3 Q28067821-05DAEB92-C657-456A-AFAF-F630E5E5EE1B Q28068318-586A1C71-467F-42F8-8A54-6A463B0ED9DB Q28076561-93CAB3D0-5D9F-4819-B5E4-23D089A04262 Q33819478-53E712DE-D3EE-40D8-9126-8E4DE7CF716E Q34152778-CC3F7216-75C5-4883-865D-77F1776346F4 Q34244877-1E35DDA9-1DC8-4819-93D8-BF159A8E01B2 Q36975357-B6EBE8B5-22DF-4D6F-A932-EDAD9B8EA890 Q37073424-70FD5517-6BBD-4209-96AE-AAA6F7D0DB5B Q37091094-7E0A6BDC-0BEF-4F1F-AD5F-DD48E11C51F4 Q37185910-2374100A-4E03-411D-B077-DFCE2F42B014 Q37216502-B41247CE-213D-4276-BE83-07E87607DE6D Q37510901-6FD244A6-1F6B-4EDD-8BBF-046217C1D0D7 Q37682503-CD577282-1907-4173-B577-70EF3FB813A8 Q37725083-DCE43D6D-0912-4DBE-90A8-829CE68C4564 Q37769252-0BEDC757-8ABB-4E44-803D-B89E0249754A Q37798819-6BC78654-E5FF-4604-80EC-26A986E8EDB9 Q37814564-0B481B34-DDB2-487E-988C-B4FE5141F332 Q38115646-4A171CE5-2162-4872-A37F-35239CBD23B9 Q38125114-5D29478B-CB48-4F92-9DFF-E4E14365451F Q38243693-F23596A9-99BF-4000-86F9-476FE027D5E1 Q38246990-1EC54EA5-02EB-4790-A18D-38963F43D651 Q38295916-3C5EC69C-1A10-493B-B795-A1F852D67AC5 Q38738250-B086491C-ABCB-4C52-BF9F-1B5AD86E1309 Q38970533-B625B4AE-DD1C-4E77-93D7-3CC62C4629E3 Q41601749-6B362C31-F09E-47F4-90E1-C3BC4CAAD607 Q45116620-C89E47FC-AAF3-4D93-A1F9-B1A4AF04C033 Q46166151-E2D14BA8-6D8A-4A47-86E1-A9A1FA7CE4B4 Q48019757-8F0182B0-C4C3-43F1-9EED-142A4EB68EB7

P2860

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

http://www.wikidata.org/entity/Q24678651

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@ast

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@en

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@nl

type

label

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@ast

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@en

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@nl

prefLabel

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@ast

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@en

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@nl

P1433

Q24678651-1BD5EB69-925C-471D-A47B-DDF00E70EF6A

P1476

Q24678651-48E80991-AE26-4FE4-B65E-F9FB70A55F57

P2093

Q24678651-15405C9F-4026-4DC0-9C40-246CF5C881AB

Q24678651-16D00407-CF95-4DE3-B809-B803765779FE

Q24678651-2D69BBAA-9440-490A-A188-75DAC0F44489

Q24678651-54FF4D3B-1B8B-4C93-9C5D-84F8EA360747

Q24678651-66A17374-A984-4379-BB4A-F148227570C0

Q24678651-A24C98C1-59A9-4952-8A70-2A2FB681F8AA

P2860

Q24678651-0E7A0222-15F9-4776-87A2-9427C2B1117E

Q24678651-2D4C32D0-DA2C-4CB0-9A8D-8411B0192FFD

Q24678651-409783F0-B467-425C-994C-3B4896C918FF

Q24678651-49C55828-F648-43E4-9904-5FE268105325

Q24678651-5BCFF42C-6926-4D1C-A3D2-7B5CF2A4E603

Q24678651-97149D7C-529F-4A31-BDD9-E837B56ECB19

Q24678651-BBAF76C3-2AB1-48A7-969A-19669A9843D1

Q24678651-E63BFFC2-D898-4BD7-9030-FE5F12DD99B6

P304

Q24678651-4DA29E60-0B89-499A-9DE9-CF7C5B6E2694

P31

Q24678651-4B57BCE1-A598-4D08-BD53-8F6896A63D0B

P3181

Q24678651-6C3E3607-3995-4121-A5A0-DCA98D331FC4

P356

Q24678651-A7C9ADDB-7115-4DA6-8C21-4C28AA03D9DC

P407

Q24678651-D5084D56-189F-4478-8C84-07E95ADD259B

P433

Q24678651-DE85F7BF-6B2D-4A62-88C6-E69A36932D92

P478

Q24678651-EBD7AAC6-09CD-4993-B121-A252188BD9FF

P577

Q24678651-F13732BA-4D53-498C-9F6C-6F3F79AB6A0C

P5875

Q24678651-C637CCEB-02A6-4B67-A4B5-AF0A31544B9A

P698

Q24678651-656B7F94-A9C0-43F4-AA97-0BC75CF45144

P932

Q24678651-CCD6A7DC-C6D1-4399-A4B0-A7F123FF4D7A

P3181

P356

J.1365-2125.2006.02639.X

P1433

British Journal of Clinical Pharmacology

P1476

Exposure to thiopurine drugs t ...... rations in mother-infant pairs

@en

P2093

Evan J Begg

http://www.w3.org/2001/XMLSchema#string

Mei Zhang

http://www.w3.org/2001/XMLSchema#string

Murray L Barclay

http://www.w3.org/2001/XMLSchema#string

Rebecca L Roberts

http://www.w3.org/2001/XMLSchema#string

Richard B Gearry

http://www.w3.org/2001/XMLSchema#string

Sharon J Gardiner

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis.

Studying drugs in human milk: time to unify the approach.

A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations.

Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.

Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.

Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine.

Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.

P304

453-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2709260

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1365-2125.2006.02639.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6798417

http://www.w3.org/2001/XMLSchema#string

P698

16995866

http://www.w3.org/2001/XMLSchema#string

P932

1885151

http://www.w3.org/2001/XMLSchema#string